Bridging Racial Disparities in Cancer Incidence and Outcomes

Bridging Racial Disparities in Cancer Incidence and Outcomes

Activity Features

  • Interactive Presentation
  • Downloadable Slides

Activity Overview

This Webcast contains video and downloadable slides from the symposium, Bridging Racial Disparities in Cancer Incidence and Outcomes, a prIME Oncology educational activity that was held on 30 July 2012 in New Orleans, Louisiana.

Topics

The challenge of disparities in medicine in the United States in 2012
David Satcher, MD, PhD

Overcoming disparities in cancer care: The role of the primary care team in cancer research
Worta McCaskill-Stevens, MD

Insights into racial disparities and breast cancer: A multifactorial challenge
William Gradishar, MD, FACP

Advances in the management of colorectal cancer
Edith Mitchell, MD, FACP

Prostate cancer: A rapidly evolving landscape
Michael A. Carducci, MD

Multiple myeloma for the primary care physician
Sagar Lonial, MD

Faculty

  • Chair
    • Warren A. Jones, MD
      University of Mississippi Medical Center
      Jackson, Mississippi, United States
  • Faculty
    • Michael Carducci, MD
      Johns Hopkins University
      Baltimore, Maryland, United States
    • William Gradishar, MD, FACP
      Northwestern University
      Robert H. Lurie Comprehensive Cancer Center
      Chicago, Illinois, United States
    • Sagar Lonial, MD
      Emory University
      Atlanta, Georgia, United States
    • Worta McCaskill-Stevens, MD
      National Cancer Institute
      Bethesda, Maryland, United States
    • Edith Mitchell, MD, FACP
      Thomas Jefferson University
      Philadelphia, Pennsylvania, United States
    • David Satcher, MD, PhD
      Morehouse School of Medicine
      Atlanta, Georgia, United States

Target Audience

This educational activity is designed for healthcare professionals involved and/or interested in racial disparities in cancer incidence and outcomes.

Learning Objectives

After successful completion of this educational activity, participants should be able to:
  • Examine racial disparities in cancer incidence and outcome, as well as the factors that contribute to these differences
  • Evaluate recent data examining racial disparities in breast cancer, colorectal cancer, prostate cancer, and multiple myeloma
  • Discuss potential diagnostic and therapeutic strategies to overcome racial disparities associated with breast cancer, colorectal cancer, prostate cancer, and multiple myeloma

Disclosures

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Conflicts of Interest

prIME Oncology assesses conflicts of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of activities. All relevant conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.

Disclosure Regarding Unlabeled Use

This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.

Organizer

This Webcast is a prIME Oncology activity.

prIME Oncology

Support

Support for this educational activity is provided by Lilly USA, LLC and Millennium: The Takeda Oncology Company.

Eli Lilly and Company

Millennium: The Takeda Oncology Company

Activity Date

RELEASE DATE
August 24, 2012

EXPIRATION DATE
August 24, 2013

Statement

Endorsed by ECOG-ACRIN Cancer Research Group, the Kimmel Cancer Center at Jefferson, and W. Montague Cobb NMA Health Institute.

ECOG-ACRIN Cancer Research Group

Kimmel Cancer Center at Jefferson

W. Montague Cobb NMA Health Institute

Continuing Education

Continue